Format

Send to

Choose Destination
Clin Transl Sci. 2018 Jan;11(1):11-20. doi: 10.1111/cts.12501. Epub 2017 Oct 23.

Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.

Author information

1
Office of Population Health Genomics, Public Health Division, Department of Health, Government of Western Australia, Perth, Australia.
2
Directorate General for Research and Innovation (DG RTD), European Commission, Brussels, Belgium, (until April 2017).
3
Merck & Co. Inc., Upper Gwynedd, Pennsylvania, USA, (from June 2017).
4
Department of Biology, McGill University, Montréal, Canada.
5
IRDiRC Scientific Secretariat, Inserm-US14, Rare Diseases Platform, Paris, France.
6
National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, Maryland, USA.
7
Orphanet, Inserm-US14, Rare Diseases Platform, Paris, France.
8
Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.
9
Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia.
10
Western Australian Register of Developmental Anomalies, Perth, Australia.
11
Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
12
EURORDIS-Rare Diseases Europe, Paris, France.
PMID:
28796411
PMCID:
PMC5759730
DOI:
10.1111/cts.12501
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center